Rapid Initiation of Naltrexone and Buprenorphine: Findings from the NIDA CTN
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Rapid Initiation of Naltrexone and Buprenorphine: Findings from the NIDA CTN
Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the risks of precipitated withdrawal during buprenorphine induction in the context of fentanyl based on quantitative data from two large trials.
This presentation will review recent findings from two large multisite trials (NIDA CTN trial 0097 and 0099) on approaches to starting XR-naltrexone and Buprenorphine safety and effectively in the age of fentanyl and real world settings. Learners will come away with practical guidance and implementation strategies for buprenorphine induction in the emergency room and the rapid approach to XR-naltrexone induction.
The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This session addresses the following ACGME Competencies: Practice-based Learning and Improvement, Systems-based Practice
This session addresses the following ICPE Competencies:Teams and Teamwork
Learning Objectives
Upon completion, learners will be able to:
- describe the risks of precipitated withdrawal during buprenorphine induction in the context of fentanyl based on quantitative data from two large trials.
- conduct the rapid approach to withdrawal management to facilitate XR-naltrexone induction.
- describe some of the real world barriers and facilitators to rapid XR-naltrexone induction and ED based buprenorphine initiation.
Registration Rates
| Rate Description | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 05/06/2024 - 04/06/2027
User Access Closed: 05/06/2027
Session Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Matisyahu Shulman, MD
Assistant Professor of Clinical Psychiatry
NYPSI - RFMH
Matisyahu Shulman MD is a research physician at the New York State Psychiatric Institute and an assistant professor of psychiatry at Columbia University Medical Center. His research focuses on multisite clinical treatment trials for opioid use disorder. He is a lead investigator or co-investigator on multiple large NIDA Clinical Trials Network studies on opioid use disorder treatment. He is also a clinical expert as part of the Opioid Response Network and has been involved in several community-based initiatives to increase awareness and decrease stigma in the area of substance use disorders. He sits on the advisory board of the Communities Confronting Substance Abuse Organization and co- founded and is the volunteer co-leader of a support group for family members of those suffering from substance use disorders.
Adam Bisaga
Professor of Clinical Psychiatry
Columbia University College of Physicians and Surgeons
Dr. Adam Bisaga is a Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons and a Research Scientist at New York State Psychiatric Institute. His NIDA-funded research is focused on development and implementation of new medications and treatment protocols to treat opioid and other substance use disorders. Dr. Bisaga is a member of UN Expert Panel. He contributed to UN and WHO addiction treatment guidances and conducts trainings and addiction treatment program developments internationally. Dr. Bisaga authored more than 100 of peer-reviewed articles, several book chapters, and a book “Overcoming Opioid Addiction“ written for professional and lay audiences. In his commitment to medical education Dr. Bisaga serves as co-director of the SAMHSA-supported “Providers’ Clinical Support System (PCSS)” a national initiative that fosters training of providers and the implementation of effective treatments for opioid use disorders and pain management. His expertise is recognized globally, he is a member of UN Office of Drugs and Crime Expert Panel and a WHO consultant and actively collaborates with United Nations agencies to train healthcare providers and develop international treatment guidelines and programs. Additionally, Dr. Bisaga is at the forefront of integrating technology in addiction healthcare as the Medical Director of Ophelia, a telehealth company specializing in the treatment of opioid use disorder.
Kathryn Hawk, MD, MHS
Associate Professor
Yale University
Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine. She was a National Institute on Drug Abuse (NIDA) K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with an emphasis on initiating medications for opioid and alcohol use disorder in the ED and maximizing effective linkage to ongoing treatment using innovative strategies. Her research on quality improvement and reducing opioid-associated mortality through data linkages, implementation-facilitation ED-initiated buprenorphine for opioid use disorder, initiating treatment for alcohol use disorder in the ED and the dissemination of evidence-based best practices for care of patients with addiction has been funded by NIDA, the Centers for Disease Control and Prevention (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Accreditation & Credit Designation Statements
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This activity awards 1.25 Nursing contact hours.
PAs
ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Continuing Education Credits (CEUs)
Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- American Board of Medical Specialties (ABMS)
- American Board of Preventive Medicine (ABPM)
- American Board of Internal Medicine (ABIM)
- American Board of Pediatrics (ABP)
- American Board of Surgery (ABS)
- American Board of Psychiatry and Neurology (ABPN)
- American Board of Addiction Medicine (ABAM)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
- Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Disclosure Information
In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.
Key:
Complete
Next
Failed
Available
Locked